Xefo Rapid 8 Mg 20 Tablets

Xefo Rapid 8 Mg 20 Tablets

Description:

Xefo Rapid 8 mg is a prescription oral pain relief medicine containing lornoxicam, a potent non‑steroidal anti‑inflammatory drug (NSAID) from the oxicam class. It is formulated as film‑coated tablets for rapid onset of analgesic, anti‑inflammatory, and antipyretic effects. Xefo Rapid is commonly used for short‑term treatment of acute moderate pain, such as musculoskeletal pain, postoperative pain, joint pain, and painful inflammatory conditions in adults. It works by inhibiting cyclooxygenase (COX‑1 and COX‑2) enzymes, reducing prostaglandin production that causes pain, inflammation, and fever.

Indications:

• Short‑term treatment of acute moderate pain in adults, such as musculoskeletal and joint pain.
• Relief of postoperative pain (after surgery), dental pain, or traumatic pain as prescribed by a physician.
• Pain associated with inflammatory conditions of the muscles, tendons, ligaments, and joints (e.g., sprains, strains) under medical supervision.
• Symptomatic relief of pain and inflammation where an NSAID is considered appropriate by the treating doctor.

Active Ingredients / Key Components:

• Lornoxicam – 8 mg per film‑coated tablet.
• Excipients (tablet core and coating) – may include fillers, binders, disintegrants, and colorants (exact excipient list and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet).

Dosage & Administration / How to Use:

• Xefo Rapid 8 mg tablets are for oral use only and should be taken exactly as prescribed by your doctor.
• Typical adult dose for acute pain (if prescribed): 8 mg two to three times daily, with a maximum total daily dose usually not exceeding 16–24 mg, depending on clinical judgment. Exact dosing regimen must be determined by the physician.
• Swallow the tablet whole with a glass of water. Do not crush or chew the film‑coated tablet.
• Can be taken with or after food to help reduce possible stomach irritation, unless your doctor advises otherwise.
• Use the lowest effective dose for the shortest possible duration to control symptoms and reduce the risk of side effects.
• Do not exceed the prescribed dose or duration of treatment. Do not use for long‑term chronic pain unless specifically instructed by your doctor.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Not recommended in children and adolescents unless specifically prescribed by a specialist (age‑specific safety data may be limited).

Clinical Benefits:

• Provides effective analgesic (pain‑relieving) action for acute moderate pain conditions.
• Offers strong anti‑inflammatory effects by inhibiting prostaglandin synthesis at the site of inflammation.
• Has antipyretic (fever‑reducing) properties, helping to lower elevated body temperature associated with inflammatory pain.
• Rapid tablet formulation designed for quicker onset of pain relief compared with some conventional NSAID tablets.
• Penetrates well into synovial fluid, making it suitable for joint and musculoskeletal pain when prescribed.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to lornoxicam, other oxicam derivatives, or any component of the formulation.
• Contraindicated in patients with a history of asthma, bronchospasm, acute rhinitis, nasal polyps, angioedema, or urticaria triggered by aspirin or other NSAIDs.
• Contraindicated in active peptic ulcer, gastrointestinal bleeding, perforation, or a history of recurrent peptic ulcers or GI bleeding.
• Contraindicated in severe heart failure, severe hepatic impairment, or severe renal impairment.
• Use with extreme caution in elderly patients, and in those with cardiovascular disease, hypertension, mild to moderate renal or hepatic impairment, or history of GI disorders.
• May increase the risk of gastrointestinal bleeding, ulceration, and perforation, which can be fatal, especially in elderly or debilitated patients.
• May increase the risk of serious cardiovascular thrombotic events (such as myocardial infarction or stroke), particularly with prolonged use or in patients with existing cardiovascular risk factors.
• Concomitant use with vitamin K antagonists (e.g., warfarin) increases bleeding risk; careful monitoring of coagulation is required.
• Concomitant use with ciclosporin can reduce kidney function and, in rare cases, cause acute renal failure; renal function monitoring is recommended.
• Lornoxicam can increase the adverse effects or blood levels of lithium, methotrexate, and digoxin; dose adjustments and monitoring may be necessary.
• May reduce the effect of diuretics, ACE inhibitors, and angiotensin II receptor antagonists, particularly in patients with compromised renal function.
• Avoid use in the third trimester of pregnancy due to risk of fetal and maternal complications; use in the first and second trimesters only if clearly needed and prescribed by a doctor.
• Not recommended during breastfeeding unless the potential benefit justifies the potential risk; consult your doctor.
• May cause dizziness, fatigue, or visual disturbances; if affected, do not drive or operate machinery.
• Consult your doctor before use if pregnant, nursing, taking medications (especially anticoagulants, diuretics, ACE inhibitors, ARBs, lithium, methotrexate, digoxin, ciclosporin), or have medical conditions such as heart disease, high blood pressure, kidney disease, liver disease, peptic ulcer, asthma, or bleeding disorders.
• Do not take other NSAIDs (e.g., ibuprofen, diclofenac, naproxen, aspirin in analgesic doses) concurrently unless directed by your doctor.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, stomach pain, indigestion, diarrhea, constipation, headache, dizziness, or fatigue.
• Gastrointestinal side effects such as heartburn, gastritis, or flatulence can occur; taking with food may help reduce stomach discomfort.
• Less common but serious side effects include gastrointestinal bleeding, ulceration, perforation, severe abdominal pain, black or bloody stools, or vomiting blood.
• Allergic reactions such as skin rash, itching, swelling of the face or throat, severe dizziness, or difficulty breathing require immediate medical attention.
• Possible effects on kidney or liver function, including changes in urine output, swelling of legs or ankles, unexplained weight gain, yellowing of skin or eyes, or dark urine; seek medical advice if these occur.
• Cardiovascular events (chest pain, shortness of breath, sudden weakness, slurred speech) are rare but serious; seek emergency care immediately.
• If any side effects become severe, persistent, or you notice any unusual symptoms, stop taking the medicine and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Form: Film‑coated tablets for oral use.
• Strength: 8 mg lornoxicam per tablet.
• Pack size: 20 tablets per pack.
• Intended use: Prescription‑only NSAID medicine for short‑term management of acute moderate pain in adults, as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.